LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the TNF-α/NF-κB pathway
Clinical and Translational Oncology · 2025
DOI: 10.1007/s12094-025-04071-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von WenRui Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Bengbu Medical University, Bengbu, 233003, Anhui, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Non-Small-Cell Lung, NF-kappa B, Lung Neoplasms. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The purpose of this research was to examine the impact of FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) on ferroptosis regulation in non-small cell lung cancer (NSCLC) cells and to understand its molecular mechanism. METHODS: The effects of FEZF1-AS1 silencing on NSCLC cell proliferation, invasion, migration, and apoptosis were evaluated through functional assays, utilizing the Cell Counting Kit-8, 5-ethynyl-2'-deoxyuridine, flow cytometry, and Transwell assays. The levels of cellular reactive oxygen species, malondialdehyde, glutathione, and Fe2+ were measured using commercial assay kits. Proteins related to ferroptosis and the tumor necrosis factor-alpha (TNF-α)/nuclear factor-κB (NF-κB) axis were analyzed using Western blot. Finally, rescue experiments were carried out by treating the cells with TNF-α. RESULTS: FEZF1-AS1 expression was significantly upregulated in NSCLC cells. Moreover, FEZF1-AS1 silencing suppressed proliferation, migration, and invasion, while enhancing ferroptosis sensitivity in NSCLC cell lines. This knockdown also inhibited the TNF-α/NF-κB pathway. TNF-α attenuated both pro-ferroptotic and anti-tumor effects of FEZF1-AS1 silencing in NSCLC cells. Mechanistically, knockdown of FEZF1-AS1 modulates ferroptosis and malignant behaviors in NSCLC cells through suppression of the TNF-α/NF-κB axis. CONCLUSION: Our study uncovers a previously unrecognized mechanistic axis in which FEZF1-AS1 promotes NSCLC progression through suppressing ferroptosis by activating the TNF-α/NF-κB axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Bengbu Medical University, Bengbu, 233003, Anhui, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University, No. 800, Zhihuai Road, Longzihu District, Bengbu, 233003, Anhui, China. Listardianming@hotmail.com.
Zitieren
APA
Hou, W., Li, D., Wang, J., & Yin, W. (2025). LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the TNF-α/NF-κB pathway. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04071-0
Vancouver
Hou W, Li D, Wang J, Yin W. LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the TNF-α/NF-κB pathway. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04071-0
BibTeX
@article{Hou2025,
author = {Hou, WenRui and Li, DianMing and Wang, JingXin and Yin, WeiQi},
title = {LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the TNF-α/NF-κB pathway},
journal = {Clinical and Translational Oncology},
year = {2025},
doi = {10.1007/s12094-025-04071-0}
}
EUVIMED